SEPSIGN: early identification of sepsis signs in emergency department.
Biomarkers
Sepsis
Triage
Journal
Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418
Informations de publication
Date de publication:
30 Oct 2024
30 Oct 2024
Historique:
received:
08
04
2024
accepted:
21
10
2024
medline:
31
10
2024
pubmed:
31
10
2024
entrez:
31
10
2024
Statut:
aheadofprint
Résumé
Because 20-30% of patients with sepsis deteriorate to critical illness, biomarkers that provide accurate early prognosis may identify which patients need more intensive treatment versus safe early discharge. The objective was to test the performance of sVEGFR2, suPAR and PCT, alone or combined with clinical signs and symptoms, for the prediction of clinical deterioration. This prospective observational study enrolled patients with suspected infection who met SIRS criteria without organ dysfunction (delta SOFA <2 from baseline) from 16 emergency departments. The primary endpoint was clinical deterioration (increased SOFA score ≥2 points, new or increased organ support, or death) within 72 hours of enrollment. Diagnosis and classification of infection status were adjudicated. 724 patients were enrolled, (54% men, median age 55 [38-70] y-o). Infection origin was abdominopelvic (21%), skin and soft tissues (17%), urinary (16%) and pulmonary (15%). 176 (24%) patients deteriorated, with a 28-day mortality of 1.4%. They had lower sVEGFR2 level (6.17 [5.00-7.40] vs 6.52 [5.40-7.84], p=0.024), higher circulating suPAR (5.25 [3.86-7.50] vs 4.18 [3.16-5.68], p<0.001) and higher PCT level (0.32 [0.08-1.80] vs 0.18 [0.05-0.98], p=0.004). suPAR demonstrated superior performance (AUC=0.65 [0.60-0.70]), compared to other biomarkers (PCT, AUC=0.57 [0.52-0.62] and sVEGFR2, AUC=0.58 [0.53-0.64]). Maximum accuracy was achieved from the combination of clinical information, sVEGFR2 and suPAR, yielding an AUC of 0.74 [0.69-0.78] and NPV 0.90 [0.88-0.94]. sVEGFR2 and suPAR were insufficiently accurate to rule out clinical deterioration. Panels of biomarkers will likely be needed to capture the heterogeneous mechanistic pathways involved in sepsis-related organ failure.
Identifiants
pubmed: 39477836
doi: 10.1007/s11739-024-03802-5
pii: 10.1007/s11739-024-03802-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI).
Références
Cecconi M, Evans L, Levy M, Rhodes A (2018) Sepsis and septic shock. Lancet 392:75–87. https://doi.org/10.1016/s0140-6736(18)30696-2
doi: 10.1016/s0140-6736(18)30696-2
pubmed: 29937192
Glickman SW, Cairns CB, Otero RM, Woods CW, Tsalik EL, Langley RJ, van Velkinburgh JC, Park LP, Glickman LT, Fowler VG Jr, Kingsmore SF, Rivers EP (2010) Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med 17:383–390. https://doi.org/10.1111/j.1553-2712.2010.00664.x
doi: 10.1111/j.1553-2712.2010.00664.x
pubmed: 20370777
Holder AL, Gupta N, Lulaj E, Furgiuele M, Hidalgo I, Jones MP, Jolly T, Gennis P, Birnbaum A (2016) Predictors of early progression to severe sepsis or shock among emergency department patients with nonsevere sepsis. Int J Emerg Med 9:10. https://doi.org/10.1186/s12245-016-0106-7
doi: 10.1186/s12245-016-0106-7
pubmed: 26908009
Pool R, Gomez H, Kellum JA (2018) Mechanisms of organ dysfunction in sepsis. Crit Care Clin 34:63–80. https://doi.org/10.1016/j.ccc.2017.08.003
doi: 10.1016/j.ccc.2017.08.003
pubmed: 29149942
Ince C, Mayeux PR, Nguyen T, Gomez H, Kellum JA, Ospina-tascón GA, Hernandez G, Murray P, De Backer D (2016) The Endothelium in Sepsis. Shock 45:259–70. https://doi.org/10.1097/shk.0000000000000473
doi: 10.1097/shk.0000000000000473
pubmed: 26871664
Lipinska-Gediga M (2016) Sepsis and septic shock-is a microcirculation a main player? Anaesthesiol Intensive Ther 48:261–265. https://doi.org/10.5603/ait.a2016.0037
doi: 10.5603/ait.a2016.0037
pubmed: 27660252
Biron BM, Ayala A, Lomas-Neira JL (2015) Biomarkers for sepsis: what is and what might be? Biomark Insights 10:7–17. https://doi.org/10.4137/bmi.s29519
doi: 10.4137/bmi.s29519
pubmed: 26417200
Barichello T, Generoso JS, Singer M, Dal-Pizzol F (2022) Biomarkers for sepsis: more than just fever and leukocytosis—a narrative review. Crit Care 26:14. https://doi.org/10.1186/s13054-021-03862-5
doi: 10.1186/s13054-021-03862-5
pubmed: 34991675
Hotchkiss RS, Tinsley KW, Swanson PE, Karl IE (2002) Endothelial cell apoptosis in sepsis. Crit Care Med 30:S225-228. https://doi.org/10.1097/00003246-200205001-00009
doi: 10.1097/00003246-200205001-00009
pubmed: 12004240
Shapiro NI, Aird WC (2011) Sepsis and the broken endothelium. Crit Care 15:135. https://doi.org/10.1186/cc10044
doi: 10.1186/cc10044
pubmed: 21457513
Vassiliou AG, Mastora Z, Orfanos SE, Jahaj E, Maniatis NA, Koutsoukou A, Armaganidis A, Kotanidou A (2014) Elevated biomarkers of endothelial dysfunction/activation at ICU admission are associated with sepsis development. Cytokine 69:240–247. https://doi.org/10.1016/j.cyto.2014.06.010
doi: 10.1016/j.cyto.2014.06.010
pubmed: 25016133
Xue M, Xu F, Yang Y, Tao Z, Chen Y, Wang S, Yin J, Min M, Shi D, Yao C, Song Z (2022) Diagnosis of sepsis with inflammatory biomarkers, cytokines, endothelial functional markers from SIRS patients. Medicine (Baltimore) 101:e28681. https://doi.org/10.1097/md.0000000000028681
doi: 10.1097/md.0000000000028681
pubmed: 35363162
Rosenberger CM, Wick KD, Zhuo H, Wu N, Chen Y, Kapadia SB et al (2023) Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis. Crit Care 27:234. https://doi.org/10.1186/s13054-023-04525-3
doi: 10.1186/s13054-023-04525-3
pubmed: 37312169
Filbin MR, Lynch J, Gillingham TD, Thorsen JE, Pasakarnis CL, Nepal S, Matsushima M, Rhee C, Heldt T, Reisner AT (2018) Presenting symptoms independently predict mortality in septic shock: importance of a previously unmeasured confounder. Crit Care Med 46:1592–1599. https://doi.org/10.1097/ccm.0000000000003260
doi: 10.1097/ccm.0000000000003260
pubmed: 29965833
Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, Iwashyna TJ (2014) Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 312:90–92. https://doi.org/10.1001/jama.2014.5804
doi: 10.1001/jama.2014.5804
pubmed: 24838355
Simons M, Gordon E, Claesson-Welsh L (2016) Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol 17(10):611–625. https://doi.org/10.1038/nrm.2016.87
doi: 10.1038/nrm.2016.87
pubmed: 27461391
Iguchi M, Wada H, Akao M, Ura S, Masunaga N, Ishii M, Unoki T, Abe M, Shimatsu A, Hasegawa K (2013) Soluble vascular endothelial growth factor receptor-2 serves as a predictor of cardiovascular events in patients with chronic heart failure. Eur Heart J 34:P4230. https://doi.org/10.1093/eurheartj/eht309.P4230
doi: 10.1093/eurheartj/eht309.P4230
Florek K, Mendyka D, Gomułka K (2024) Vascular endothelial growth factor (VEGF) and its role in the cardiovascular system. Biomedicines 12(5):1055. https://doi.org/10.3390/biomedicines12051055
doi: 10.3390/biomedicines12051055
pubmed: 38791016
Del Rosso M, Margheri F, Serratì S, Chillà A, Laurenzana A, Fibbi G (2011) The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. Curr Pharm Des 17(19):1924–1943. https://doi.org/10.2174/138161211796718189
doi: 10.2174/138161211796718189
pubmed: 21711238
Zeng M, Chang M, Zheng H, Li B, Chen Y, He W, Huang C (2016) Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis. Am J Emerg Med 34(3):375–380. https://doi.org/10.1016/j.ajem.2015.11.004
doi: 10.1016/j.ajem.2015.11.004
pubmed: 26615223
Ismail A, Hayek SS (2023) Role of soluble urokinase-type plasminogen activator receptor in cardiovascular disease. Curr Cardiol Rep 25(12):1797–1810. https://doi.org/10.1007/s11886-023-01991-7
doi: 10.1007/s11886-023-01991-7
pubmed: 37948017
Goodchild TT, Li Z, Lefer DJ (2022) Soluble urokinase plasminogen activator receptor: from biomarker to active participant in atherosclerosis and cardiovascular disease. J Clin Invest 132(24):e165868. https://doi.org/10.1172/jci165868
doi: 10.1172/jci165868
pubmed: 36519539
pmcid: 9754098
Peiró ÓM, Cediel G, Bonet G, Rojas S, Quintern V, Carrasquer A, González-Del-Hoyo M, Sanz E, Bardají A (2020) Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes. Biomarkers 25(5):402–409. https://doi.org/10.1080/1354750X.2020.1778090
doi: 10.1080/1354750X.2020.1778090
pubmed: 32551985
Lafon T, Cazalis M-A, Vallejo C, Tazarourte K, Blein S, Pachot A, Laterre PF, Laribi S, François B, TRIAGE study group, (2020) Prognostic performance of endothelial biomarkers to early predict clinical deterioration of patients with suspected bacterial infection and sepsis admitted to the emergency department. Ann Intensive Care 10:113. https://doi.org/10.1186/s13613-020-00729-w
doi: 10.1186/s13613-020-00729-w
pubmed: 32785865
pmcid: 7423829
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. https://doi.org/10.1136/bmj.h5527
doi: 10.1136/bmj.h5527
pubmed: 26511519
pmcid: 4623764
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 101:1644–1655. https://doi.org/10.1378/chest.101.6.1644
doi: 10.1378/chest.101.6.1644
pubmed: 1303622
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810. https://doi.org/10.1001/jama.2016.0287
doi: 10.1001/jama.2016.0287
pubmed: 26903338
Hausfater P, Brochet C, Freund Y, Charles V, Bernard M (2010) Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays. Clin Chem Lab Med 48:501–504. https://doi.org/10.1515/cclm.2010.091
doi: 10.1515/cclm.2010.091
pubmed: 20148728
Saeed K, Wilson DC, Bloos F, Schuetz P, van der Does Y, Melander O et al (2019) The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study. Crit Care 23:40. https://doi.org/10.1186/s13054-019-2329-5
doi: 10.1186/s13054-019-2329-5
pubmed: 30736862
Simpson SQ (2019) Sepsis biomarkers and physician judgment in the emergency room. Crit Care Med 47:1656–1657. https://doi.org/10.1097/ccm.0000000000003983
doi: 10.1097/ccm.0000000000003983
pubmed: 31609261
Henning DJ, Bhatraju PK, Johnson NJ, Kosamo S, Shapiro NI, Zelnick LR, Liles WC, Wurfel MM (2019) Physician judgment and circulating biomarkers predict 28-day mortality in emergency department patients. Crit Care Med 47:1513–1521. https://doi.org/10.1097/ccm.0000000000003899
doi: 10.1097/ccm.0000000000003899
pubmed: 31369425
Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C (2007) Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 35:199–206. https://doi.org/10.1097/01.ccm.0000251640.77679.d7
doi: 10.1097/01.ccm.0000251640.77679.d7
pubmed: 17110873
Thanh Duyen LT, Manh BV, Phuong Thao TT, Khanh LV, Linh Trang BN, Giang NT, Quang HV, Viet NT, Hang NT, Mao CV, Toan NL, Tong HV (2023) Prognostic significance of the angiopoietin-2 for early prediction of septic shock in severe sepsis patients. Future Sci OA. https://doi.org/10.2144/fsoa-2022-0077
doi: 10.2144/fsoa-2022-0077
pubmed: 36874368
Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, Lafferty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, Kain KC, Liaw PC, Liles WC (2011) Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis *. Crit Care Med 39:702–710. https://doi.org/10.1097/ccm.0b013e318206d285
doi: 10.1097/ccm.0b013e318206d285
pubmed: 21242795
Liu X-W, Ma T, Liu W, Cai Q, Wang L, Song H-W, Yuan L, Liu Z (2018) Sustained increase in angiopoietin-2, heparin-binding protein, and procalcitonin is associated with severe sepsis. J Crit Care 45:14–19. https://doi.org/10.1016/j.jcrc.2018.01.010
doi: 10.1016/j.jcrc.2018.01.010
pubmed: 29413717
Lymperopoulou K, Velissaris D, Kotsaki A, Antypa E, Georgiadou S, Tsaganos T, Koulenti D, Paggalou E, Damoraki G, Karagiannidis N, Orfanos SE (2015) Angiopoietin-2 associations with the underlying infection and sepsis severity. Cytokine 73:163–168. https://doi.org/10.1016/j.cyto.2015.01.022
doi: 10.1016/j.cyto.2015.01.022
pubmed: 25748839
Zhang C, Shang X, Yuan Y, Li Y (2023) Platelet-related parameters as potential biomarkers for the prognosis of sepsis. Exp Ther Med 25:133. https://doi.org/10.3892/etm.2023.11832
doi: 10.3892/etm.2023.11832
pubmed: 36845958
Rasmussen LJH, Ladelund S, Haupt TH, Ellekilde G, Poulsen JH, Iversen K, Eugen-Olsen J, Andersen O (2016) Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study. Emerg Med J 33:769–775. https://doi.org/10.1136/emermed-2015-205444
doi: 10.1136/emermed-2015-205444
pubmed: 27590986
Tavenier J, Rasmussen LJH, Tolstrup J, Petersen J, Sobocki J, Pisinger C, Eugen-Olsen J, Gamst-Jensen H (2022) Self-rated health and chronic inflammation are related and independently associated with hospitalization and long-term mortality in the general population. Sci Rep 12:19761. https://doi.org/10.1038/s41598-022-24422-z
doi: 10.1038/s41598-022-24422-z
pubmed: 36396700
Schultz M, Rasmussen LJH, Carlson N, Hasselbalch RB, Jensen BN, Usinger L, Eugen-Olsen J, Torp-Pedersen C, Rasmussen LS, Iversen KK (2019) Risk assessment models for potential use in the emergency department have lower predictive ability in older patients compared to the middle-aged for short-term mortality – a retrospective cohort study. BMC Geriatr 19:134. https://doi.org/10.1186/s12877-019-1154-7
doi: 10.1186/s12877-019-1154-7
pubmed: 31096925
pmcid: 6521424
Raven W, de Hond A, Bouma L-M, Mulder L, de Groot B (2023) Does machine learning combined with clinical judgment outperform clinical judgment alone in predicting in-hospital mortality in old and young suspected infection emergency department patients? Eur J Emerg Med 30:205–206. https://doi.org/10.1097/mej.0000000000000996
doi: 10.1097/mej.0000000000000996
pubmed: 37103898